
Cinven, EQT target new geographies
European buyout houses Cinven and EQT have been looking further afield for healthcare investments, this week buying US-based CRO business Medpace and Australian radiology specialist I-Med, respectively.
Earlier this week, Cinven announced the acquisition of a majority stake in Medpace, a US-based contract research organisation (CRO) from CCMP for a total consideration of $915m.
The business provides management services to the R&D departments of clients in the life sciences sector to help plan and oversee clinical trials. Established in 1992, Medpace is headquartered in Cincinnati and operates in 45 countries. The company generated an adjusted EBITDA of $94m in 2013.
According to Cinven's own portfolio listing, this marked the GP's first investment in a US-based company.
Meanwhile, EQT has entered talks to acquire Australian radiology business I-Med from its hedge-fund owners, in what also marks the GP's first foray into the country. The deal is reportedly worth in the region of A$400m.
I-Med provides medical imaging services across 200 clinics in Australia. The company's EBITDA reportedly stands at around A$79m. I-Med is no stranger to private equity, having already been owned by CVC between 2006 and 2011 – the company came close to the brink at the time and was ultimately taken over by its lenders.
Both Cinven and EQT have raised substantial vehicles in recent months. The former closed its fifth buyout fund on €5.3bn in the first half of last year, while EQT held a final close for its latest mid-market vehicle on €1.1bn at the end of January.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater